Notably, SLX4 complex activities have also been implicated in telomere processing mechanisms, particularly at hyperextended telomeres like those of ALT+ cancer cells (Sarkar et al., 2015; Vannier et al., 2012; Wan et al., 2013). This evidence concerns the gene SLX4 and cancer.